Wolfhard Frost · Bessemerweg 13 · 33611 Bielefeld
E-Mail: info@prostata-sh.info

PSA Selbsthilfegruppe Prostatakrebs Bielefeld

Late stage CRPCa

17.8.2010

CRPCa is the end-stage of a multifactorial and cancerheterogeneous disease process. Upregulation of androgen receptor (AR) expression has been recognized a major determinant for the development of CRPCa.
There are currently few effective therapies for castration-resistant prostate cancer (CRPCa). Docetaxel based chemotherapy has been shown to modestly extend life, relieve pain and improve the quality of life in patients with metastatic castration-resistant prostate .


Schlagwörter:


Zurück